|
시장보고서
상품코드
2151499
세포 증식 키트 시장 규모, 점유율, 동향 분석 보고서 : 제품 유형별, 어세이 유형별, 검출 방법별, 용도별, 지역별 및 부문별 예측(2026-2033년)Cell Proliferation Kit Market Size, Share & Trends Analysis Report By Product Type, By Assay Type, By Detection Method, By Application, By Region, And Segment Forecasts, 2026 - 2033 |
||||||
가격
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
세포 증식 키트 시장 요약
세계의 세포 증식 키트 시장 규모는 2025년에 4억 9,820만 달러로 평가되며, 2026년 5억 1,940만 달러에서 2033년까지 7억 960만 달러로 성장할 것으로 예상되며, 2026년부터 2033년까지 연평균 성장률(CAGR)은 4.6%에 달할 것으로 예측됩니다.
2025년에는 북미 시장이 매출 점유율의 41.2%를 차지하며 시장을 주도했습니다. 시장의 성장은 세포 기반 분석법의 채택 확대, 신약 개발 및 독성 시험에 대한 수요 증가, 그리고 암 연구, 의약품 개발, 학술 연구 분야에서 세포 증식 키트의 활용 확대에 의해 주도되고 있습니다.
자주 묻는 질문
목차
제1장 조사 방법과 범위
제2장 주요 요약
제3장 시장 : 변수, 동향, 범위
- 시장 계보 전망
- 시장 역학
- 업계 분석 도구
제4장 제품 유형별 비즈니스 분석
- 세포 증식 키트 시장 : 제품 유형별 변동 분석
- 비색 측정 키트
- 형광 측정 키트
- 발광 키트
- 기타 증식 키트
제5장 어세이 유형별 비즈니스 분석
- 세포 증식 키트 시장 : 어세이 유형별 변동 분석
- DNA 합성 어세이
- 대사 활성 어세이
- 세포 분열/ 색소 희석 어세이
- 단백질/항원 기반 어세이
- 기타 어세이 유형
제6장 검출 방법 비즈니스 분석
- 세포 증식 키트 시장 : 검출 방법 변동 분석
- 흡광도에 기반한 검출
- 형광법을 이용한 검출
- 발광을 이용한 검출
- 유세포 분석을 이용한 검출
- 영상에 기반한 검출
- 기타 검출 방법
제7장 용도별 비즈니스 분석
- 세포 증식 키트 시장 : 용도별 변동 분석
- Drug Discovery & Development
- 암 연구
- 줄기세포 및 재생의료 조사
- 독성 및 안전성 시험
- 기초 및 학술적인 세포생물학 조사
- 기타 용도
제8장 지역별 비즈니스 분석
- 지역별 세포 증식 키트 시장 점유율(2025년 및 2033년)
- 북미
- 북미의 세포 증식 키트 시장, 2021-2033년
- 미국
- 캐나다
- 멕시코
- 유럽
- 유럽의 세포 증식 키트 시장, 2021-2033년
- 영국
- 독일
- 프랑스
- 이탈리아
- 스페인
- 덴마크
- 스웨덴
- 노르웨이
- 아시아태평양
- 아시아태평양의 세포 증식 키트 시장, 2021-2033년
- 일본
- 중국
- 인도
- 호주
- 태국
- 한국
- 라틴아메리카
- 라틴아메리카의 세포 증식 키트 시장, 2021-2033년
- 브라질
- 아르헨티나
- 중동 및 아프리카
- 중동 및 아프리카의 세포 증식 키트 시장, 2021-2033년
- 남아프리카공화국
- 사우디아라비아
- UAE
- 쿠웨이트
제9장 경쟁 구도
- 기업 분류
- 기업 점유율·포지셔닝 분석, 2025년
- 전략 매핑
- 기업 개요·리스트
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Bio-Rad Laboratories, Inc.
- Revvity
- Agilent Technologies, Inc.
- Promega Corporation
- Abcam plc(subsidiary of Danaher Corporation)
- Biotium, Inc.
- Lonza
- AAT Bioquest, Inc.
Cell Proliferation Kit Market Summary
The global cell proliferation kit market size was valued at USD 498.2 million in 2025 and is projected to grow from USD 519.4 million in 2026 to USD 709.6 million by 2033, at a CAGR of 4.6% from 2026 to 2033. The market in North America dominated with a revenue share of 41.2% in 2025. The market growth is driven by increasing adoption of cell-based assays, rising demand for drug discovery and toxicity testing, and expanding applications of cell proliferation kits in cancer research, pharmaceutical development, and academic research.
Global Cell Proliferation Kit Market Report Segmentation
This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For the purpose of this report, Grand View Research has segmented the cell proliferation kit industry on the basis of product type, assay type, detection method, application and region.
- Product Type Outlook (Revenue, USD Million, 2021 - 2033)
- Colorimetric Kits
- Fluorometric Kits
- Luminescent Kits
- Other Proliferation Kits
- Assay Type Outlook (Revenue, USD Million, 2021 - 2033)
- DNA Synthesis Assays
- Metabolic Activity Assays
- Cell Division / Dye-Dilution Assays
- Protein/Antigen-based Assays
- Other Assay Types
- Detection Method Outlook (Revenue, USD Million, 2021 - 2033)
- Absorbance-based Detection
- Fluorescence-based Detection
- Luminescence-based Detection
- Flow Cytometry-based Detection
- Imaging-based Detection
- Other Detection Methods
- Application Outlook (Revenue, USD Million, 2021 - 2033)
- Drug Discovery & Development
- Cancer Research
- Stem Cell & Regenerative Medicine Research
- Toxicity & Safety Testing
- Basic & Academic Cell Biology Research
- Other Applications
- Regional Outlook (Revenue, USD Million, 2021 - 2033)
- North America
- U.S.
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- Japan
- China
- India
- Australia
- Thailand
- South Korea
- Latin America
- Brazil
- Argentina
- Middle East and Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Kuwait
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.1.1. Segment Definitions
- 1.1.1.1. Product Type
- 1.1.1.2. Assay Type
- 1.1.1.3. Detection Method
- 1.1.1.4. Application
- 1.1.1. Segment Definitions
- 1.2. Regional Scope
- 1.3. Estimates and Forecast Timeline
- 1.4. Objectives
- 1.5. Research Methodology
- 1.6. Information Procurement
- 1.6.1. Purchased Database
- 1.6.2. GVR's Internal Database
- 1.6.3. Secondary Sources
- 1.6.4. Primary Research
- 1.7. Information or Data Analysis:
- 1.7.1. Data Analysis Models
- 1.8. Market Formulation & Validation
- 1.9. Model Details
- 1.9.1. Commodity Flow Analysis
- 1.9.2. List of Secondary Sources
- 1.9.3. List of Abbreviations
Chapter 2. Executive Summary
- 2.1. Market Snapshot
- 2.2. Segment Snapshot
- 2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/Ancillary Market Outlook
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.1.1. Increasing Adoption of Cell Proliferation Kit in Immunology Research
- 3.2.1.2. Increasing Adoption of Cell Proliferation Assays in Drug Discovery and Toxicology
- 3.2.1.3. Growing Use of Cell Proliferation Kits in Advanced Cell-Based Research
- 3.2.2. Market Restraint Analysis
- 3.2.2.1. Limitations in the Accuracy of Cell Proliferation Assays
- 3.2.2.2. Reproducibility Challenges in Cell-Based Proliferation Testing
- 3.2.3. Market Opportunities Analysis
- 3.2.4. Market Challenges Analysis
- 3.2.1. Market Driver Analysis
- 3.3. Industry Analysis Tools
- 3.3.1. Porter's Five Forces Analysis
- 3.3.1.1. Supplier power
- 3.3.1.2. Buyer power
- 3.3.1.3. Substitution threat
- 3.3.1.4. Threat of new entrant
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTLE Analysis
- 3.3.2.1. Political landscape
- 3.3.2.2. Technological landscape
- 3.3.2.3. Social landscape
- 3.3.2.4. Economic landscape
- 3.3.2.5. Legal landscape
- 3.3.1. Porter's Five Forces Analysis
Chapter 4. Product Type Business Analysis
- 4.1. Segment Dashboard
- 4.2. Cell Proliferation Kits Market: Product Type Movement Analysis
- 4.3. Colorimetric Kits
- 4.3.1. Colorimetric Kits Market, 2021-2033 (USD Million)
- 4.4. Fluorometric Kits
- 4.4.1. Fluorometric Kits Market, 2021-2033 (USD Million)
- 4.5. Luminescent Kits
- 4.5.1. Luminescent Kits Market, 2021-2033 (USD Million)
- 4.6. Other Proliferation Kits
- 4.6.1. Other Proliferation Kits Market, 2021-2033 (USD Million)
Chapter 5. Assay Type Business Analysis
- 5.1. Segment Dashboard
- 5.2. Cell Proliferation Kits Market: Assay Type Movement Analysis
- 5.3. DNA Synthesis Assays
- 5.3.1. DNA Synthesis Assays Market, 2021-2033 (USD Million)
- 5.4. Metabolic Activity Assays
- 5.4.1. Metabolic Activity Assays Market, 2021-2033 (USD Million)
- 5.5. Cell Division / Dye-Dilution Assays
- 5.5.1. Cell Division / Dye-Dilution Assays Market, 2021-2033 (USD Million)
- 5.6. Protein/Antigen-based Assays
- 5.6.1. Protein/Antigen-based Assays Market, 2021-2033 (USD Million)
- 5.7. Other Assay Types
- 5.7.1. Other Assay Types Market, 2021-2033 (USD Million)
Chapter 6. Detection Method Business Analysis
- 6.1. Segment Dashboard
- 6.2. Cell Proliferation Kits Market: Detection Method Movement Analysis
- 6.3. Absorbance-based Detection
- 6.3.1. Absorbance-based Detection Market, 2021-2033 (USD Million)
- 6.4. Fluorescence-based Detection
- 6.4.1. Fluorescence-based Detection Market, 2021-2033 (USD Million)
- 6.5. Luminescence-based Detection
- 6.5.1. Luminescence-based Detection Market, 2021-2033 (USD Million)
- 6.6. Flow Cytometry-based Detection
- 6.6.1. Flow Cytometry-based Detection Market, 2021-2033 (USD Million)
- 6.7. Imaging-based Detection
- 6.7.1. Imaging-based Detection Market, 2021-2033 (USD Million)
- 6.8. Other Detection Methods
- 6.8.1. Other Detection Methods Market, 2021-2033 (USD Million)
Chapter 7. Application Business Analysis
- 7.1. Segment Dashboard
- 7.2. Cell Proliferation Kits Market: Application Movement Analysis
- 7.3. Drug Discovery & Development
- 7.3.1. Drug Discovery & Development Market, 2021-2033 (USD Million)
- 7.4. Cancer Research
- 7.4.1. Cancer Research Market, 2021-2033 (USD Million)
- 7.5. Stem Cell & Regenerative Medicine Research
- 7.5.1. Stem Cell & Regenerative Medicine Research Market, 2021-2033 (USD Million)
- 7.6. Toxicity & Safety Testing
- 7.6.1. Toxicity & Safety Testing Market, 2021-2033 (USD Million)
- 7.7. Basic & Academic Cell Biology Research
- 7.7.1. Basic & Academic Cell Biology Research Market, 2021-2033 (USD Million)
- 7.8. Other Applications
- 7.8.1. Other Applications Market, 2021-2033 (USD Million)
Chapter 8. Regional Business Analysis
- 8.1. Cell Proliferation Kits Market Share By Region, 2025 & 2033
- 8.2. North America
- 8.2.1. North America Cell Proliferation Kits Market, 2021-2033 (USD Million)
- 8.2.2. U.S.
- 8.2.2.1. Key Country Dynamics
- 8.2.2.2. Competitive Scenario
- 8.2.2.3. Regulatory Framework
- 8.2.2.4. U.S. Cell Proliferation Kits Market, 2021-2033 (USD Million)
- 8.2.3. Canada
- 8.2.3.1. Key Country Dynamics
- 8.2.3.2. Competitive Scenario
- 8.2.3.3. Regulatory Framework
- 8.2.3.4. Canada Cell Proliferation Kits Market, 2021-2033 (USD Million)
- 8.2.4. Mexico
- 8.2.4.1. Key Country Dynamics
- 8.2.4.2. Competitive Scenario
- 8.2.4.3. Regulatory Framework
- 8.2.4.4. Mexico Cell Proliferation Kits Market, 2021-2033 (USD Million)
- 8.3. Europe
- 8.3.1. Europe Cell Proliferation Kits Market, 2021-2033 (USD Million)
- 8.3.2. UK
- 8.3.2.1. Key Country Dynamics
- 8.3.2.2. Competitive Scenario
- 8.3.2.3. Regulatory Framework
- 8.3.2.4. UK Cell Proliferation Kits Market, 2021-2033 (USD Million)
- 8.3.3. Germany
- 8.3.3.1. Key Country Dynamics
- 8.3.3.2. Competitive Scenario
- 8.3.3.3. Regulatory Framework
- 8.3.3.4. Germany Cell Proliferation Kits Market, 2021-2033 (USD Million)
- 8.3.4. France
- 8.3.4.1. Key Country Dynamics
- 8.3.4.2. Competitive Scenario
- 8.3.4.3. Regulatory Framework
- 8.3.4.4. France Cell Proliferation Kits Market, 2021-2033 (USD Million)
- 8.3.5. Italy
- 8.3.5.1. Key Country Dynamics
- 8.3.5.2. Competitive Scenario
- 8.3.5.3. Regulatory Framework
- 8.3.5.4. Italy Cell Proliferation Kits Market, 2021-2033 (USD Million)
- 8.3.6. Spain
- 8.3.6.1. Key Country Dynamics
- 8.3.6.2. Competitive Scenario
- 8.3.6.3. Regulatory Framework
- 8.3.6.4. Spain Cell Proliferation Kits Market, 2021-2033 (USD Million)
- 8.3.7. Denmark
- 8.3.7.1. Key Country Dynamics
- 8.3.7.2. Competitive Scenario
- 8.3.7.3. Regulatory Framework
- 8.3.7.4. Denmark Cell Proliferation Kits Market, 2021-2033 (USD Million)
- 8.3.8. Sweden
- 8.3.8.1. Key Country Dynamics
- 8.3.8.2. Competitive Scenario
- 8.3.8.3. Regulatory Framework
- 8.3.8.4. Sweden Cell Proliferation Kits Market, 2021-2033 (USD Million)
- 8.3.9. Norway
- 8.3.9.1. Key Country Dynamics
- 8.3.9.2. Competitive Scenario
- 8.3.9.3. Regulatory Framework
- 8.3.9.4. Norway Cell Proliferation Kits Market, 2021-2033 (USD Million)
- 8.4. Asia Pacific
- 8.4.1. Asia Pacific Cell Proliferation Kits Market, 2021-2033 (USD Million)
- 8.4.2. Japan
- 8.4.2.1. Key Country Dynamics
- 8.4.2.2. Competitive Scenario
- 8.4.2.3. Regulatory Framework
- 8.4.2.4. Japan Cell Proliferation Kits Market, 2021-2033 (USD Million)
- 8.4.3. China
- 8.4.3.1. Key Country Dynamics
- 8.4.3.2. Competitive Scenario
- 8.4.3.3. Regulatory Framework
- 8.4.3.4. China Cell Proliferation Kits Market, 2021-2033 (USD Million)
- 8.4.4. India
- 8.4.4.1. Key Country Dynamics
- 8.4.4.2. Competitive Scenario
- 8.4.4.3. Regulatory Framework
- 8.4.4.4. India Cell Proliferation Kits Market, 2021-2033 (USD Million)
- 8.4.5. Australia
- 8.4.5.1. Key Country Dynamics
- 8.4.5.2. Competitive Scenario
- 8.4.5.3. Regulatory Framework
- 8.4.5.4. Australia Cell Proliferation Kits Market, 2021-2033 (USD Million)
- 8.4.6. Thailand
- 8.4.6.1. Key Country Dynamics
- 8.4.6.2. Competitive Scenario
- 8.4.6.3. Regulatory Framework
- 8.4.6.4. Thailand Cell Proliferation Kits Market, 2021-2033 (USD Million)
- 8.4.7. South Korea
- 8.4.7.1. Key Country Dynamics
- 8.4.7.2. Competitive Scenario
- 8.4.7.3. Regulatory Framework
- 8.4.7.4. South Korea Cell Proliferation Kits Market, 2021-2033 (USD Million)
- 8.5. Latin America
- 8.5.1. Latin America Cell Proliferation Kits Market, 2021-2033 (USD Million)
- 8.5.2. Brazil
- 8.5.2.1. Key Country Dynamics
- 8.5.2.2. Competitive Scenario
- 8.5.2.3. Regulatory Framework
- 8.5.2.4. Brazil Cell Proliferation Kits Market, 2021-2033 (USD Million)
- 8.5.3. Argentina
- 8.5.3.1. Key Country Dynamics
- 8.5.3.2. Competitive Scenario
- 8.5.3.3. Regulatory Framework
- 8.5.3.4. Argentina Cell Proliferation Kits Market, 2021-2033 (USD Million)
- 8.6. MEA
- 8.6.1. MEA Cell Proliferation Kits Market, 2021-2033 (USD Million)
- 8.6.2. South Africa
- 8.6.2.1. Key Country Dynamics
- 8.6.2.2. Competitive Scenario
- 8.6.2.3. Regulatory Framework
- 8.6.2.4. South Africa Cell Proliferation Kits Market, 2021-2033 (USD Million)
- 8.6.3. Saudi Arabia
- 8.6.3.1. Key Country Dynamics
- 8.6.3.2. Competitive Scenario
- 8.6.3.3. Regulatory Framework
- 8.6.3.4. Saudi Arabia Cell Proliferation Kits Market, 2021-2033 (USD Million)
- 8.6.4. UAE
- 8.6.4.1. Key Country Dynamics
- 8.6.4.2. Competitive Scenario
- 8.6.4.3. Regulatory Framework
- 8.6.4.4. UAE Cell Proliferation Kits Market, 2021-2033 (USD Million)
- 8.6.5. Kuwait
- 8.6.5.1. Key Country Dynamics
- 8.6.5.2. Competitive Scenario
- 8.6.5.3. Regulatory Framework
- 8.6.5.4. Kuwait Cell Proliferation Kits Market, 2021-2033 (USD Million)
Chapter 9. Competitive Landscape
- 9.1. Company Categorization
- 9.2. Company Market Share/ Position Analysis, 2025
- 9.3. Strategy Mapping
- 9.4. Company Profiles/Listing
- 9.4.1. Thermo Fisher Scientific Inc.
- 9.4.1.1. Overview
- 9.4.1.2. Financial Performance
- 9.4.1.3. Product Benchmarking
- 9.4.1.4. Strategic Initiatives
- 9.4.2. Merck KGaA
- 9.4.2.1. Overview
- 9.4.2.2. Financial Performance
- 9.4.2.3. Product Benchmarking
- 9.4.2.4. Strategic Initiatives
- 9.4.3. Bio-Rad Laboratories, Inc.
- 9.4.3.1. Overview
- 9.4.3.2. Financial Performance
- 9.4.3.3. Product Benchmarking
- 9.4.3.4. Strategic Initiatives
- 9.4.4. Revvity
- 9.4.4.1. Overview
- 9.4.4.2. Financial Performance
- 9.4.4.3. Product Benchmarking
- 9.4.4.4. Strategic Initiatives
- 9.4.5. Agilent Technologies, Inc.
- 9.4.5.1. Overview
- 9.4.5.2. Financial Performance
- 9.4.5.3. Product Benchmarking
- 9.4.5.4. Strategic Initiatives
- 9.4.6. Promega Corporation
- 9.4.6.1. Overview
- 9.4.6.2. Financial Performance
- 9.4.6.3. Product Benchmarking
- 9.4.6.4. Strategic Initiatives
- 9.4.7. Abcam plc (subsidiary of Danaher Corporation)
- 9.4.7.1. Overview
- 9.4.7.2. Financial Performance
- 9.4.7.3. Product Benchmarking
- 9.4.7.4. Strategic Initiatives
- 9.4.8. Biotium, Inc.
- 9.4.8.1. Overview
- 9.4.8.2. Financial Performance
- 9.4.8.3. Product Benchmarking
- 9.4.8.4. Strategic Initiatives
- 9.4.9. Lonza
- 9.4.9.1. Overview
- 9.4.9.2. Financial Performance
- 9.4.9.3. Product Benchmarking
- 9.4.9.4. Strategic Initiatives
- 9.4.10. AAT Bioquest, Inc.
- 9.4.10.1. Overview
- 9.4.10.2. Financial Performance
- 9.4.10.3. Product Benchmarking
- 9.4.10.4. Strategic Initiatives
- 9.4.1. Thermo Fisher Scientific Inc.
